CBDX (Curative Biosciences) Pretax Margin %: % (As of Mar. 2018)


What is Curative Biosciences Pretax Margin %?

Curative Biosciences CBDX Pretax Margin % is % as of Mar. 2018.

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Curative Biosciences's Pre-Tax Income for the three months ended in Mar. 2018 was $-0.03 Mil. Curative Biosciences's Revenue for the three months ended in Mar. 2018 was $0.00 Mil. Therefore, Curative Biosciences's pretax margin for the quarter that ended in Mar. 2018 was %.

The historical rank and industry rank for Curative Biosciences's Pretax Margin % or its related term are showing as below:


CBDX's Pretax Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 7.3
* Ranked among companies with meaningful Pretax Margin % only.

Curative Biosciences  (OTCPK:CBDX) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

Curative Biosciences Pretax Margin % Related Terms

Curative Biosciences Pretax Margin % Historical Data

* Premium members only.

The historical data trend for Curative Biosciences's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Curative Biosciences Pretax Margin % Chart

Curative Biosciences Annual Data
Trend Jun08 Jun09 Jun10 Jun11 Jun12 Jun13 Jun14 Jun15 Jun16 Jun17
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4,097.53 0.00 0.00 0.00 0.00

Curative Biosciences Quarterly Data
Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

CBDX vs ACUR, CVLB, RDGL: Pretax Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Curative Biosciences's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Curative Biosciences Pretax Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Curative Biosciences's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Curative Biosciences's Pretax Margin % falls into.


Curative Biosciences Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Curative Biosciences's Pretax Margin for the fiscal year that ended in Jun. 2017 is calculated as

Pretax Margin=Pre-Tax Income (A: Jun. 2017 )/Revenue (A: Jun. 2017 )
=-0.053/0
= %

Curative Biosciences's Pretax Margin for the quarter that ended in Mar. 2018 is calculated as

Pretax Margin=Pre-Tax Income (Q: Mar. 2018 )/Revenue (Q: Mar. 2018 )
=-0.032/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Pretax Margin % →
What does a Pretax Margin % of % mean?
Curative Biosciences (CBDX) has a Pretax Margin % of % as of Mar. 2018. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Curative Biosciences and its competitors.
Is Curative Biosciences' Pretax Margin % too high?
Curative Biosciences' current Pretax Margin % is %.
How does Curative Biosciences' Pretax Margin % compare to ACUR and CVLB?
Curative Biosciences' Pretax Margin % of % can be compared against companies in the Drug Manufacturers industry. The industry median Pretax Margin % is 7.30. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Drug Manufacturers company?
The median Pretax Margin % among Drug Manufacturers companies is 7.30, based on 953 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Curative Biosciences and its competitors. For the Drug Manufacturers industry, the median Pretax Margin % is 7.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Curative Biosciences's current Pretax Margin % is %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Curative Biosciences stock overvalued right now?
Curative Biosciences (CBDX) has a current Pretax Margin % of %. The current Pretax Margin % is %. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Curative Biosciences (CBDX), the current Pretax Margin % is % as of Mar. 2018. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Curative Biosciences Business Description

Address 2 South Biscayne Boulevard, Suite 3760, Miami, FL, USA, 33131
Curative Biosciences Inc is a life sciences company focused on developing and commercializing novel therapeutics using hemp-derived CBD. Its products comprise of CBD softgels, Hemp oil, and Topicals.